Dr Reddy s announces commercialisation of Vozet in India

Hyderabad July 18 (IANS) Pharma major Dr Reddy s Laboratories on Tuesday announced the commercialisation of Vozet tablets in India used for the treatment of allergic Rhinitis and chronic Urticaria.

The Vozet tablets contain Levocetirizine 5 mg and are available in a strip size of 10 the Hyderabad-headquartered company said in a statement.

The anti-histamine market in India had sales of Rs 1 038 crore MAT (Moving Annual Total) for the most recent 12 months ended March 2017 according to information technology company for the healthcare industry IMS ORG.

Dr Reddy s will further strengthen its anti-allergy portfolio with the addition of Vozet said the statement.

--IANS
ms/vgu/dg